专利检索 ap:("ADVERIO PHARMA GMBH") AND inv:"Peter Sandner" 第 1 页

1.

发明授权
Method of identifying a subgroup of patients suffering from dcSSc which benefits from a treatment with sGC stimulators and sGC activators in a higher degree than a control group 有权

公开(公告)号：US11508483B2

公开(公告)日：2022-11-22

申请号：US16423371

申请日：2019-05-28

申请人： ADVERIO PHARMA GMBH

发明人： Peter Sandner , Melanie Hemmrich , Janethe De Oliveira Pena , Stephen Dawe

IPC分类号： G16H50/30 , G16H50/50 , G16H50/70 , G16H50/20 , G01N33/564

摘要： The present invention relates to a method of identifying a subgroup of patients suffering from diffuse cutaneous systemic sclerosis (dcSSc) which subgroup of patients benefits from a treatment with at least one sGC stimulator and/or sGC activator in a higher degree than patients not belonging to this subgroup.